EMCM is the centre of excellence in developing and manufacturing sterile medicinal products in GMP and ISO accredited facilities that cater to the markets of innovative Biomaterials, Pharmaceuticals and Tissue Engineering specialties conforming to the standards of the USFDA, EMEA and ISO.
As a customer driven organisation that believes in contributing to the quality of life by delivering high quality products and services, EMCM incorporates a "no-compromise on quality" policy, your innovations are delivered in the safest of environments.
EMCM prides itself in being able to support innovations and breakthroughs in the healthcare sector that will positively impact the lives of millions worldwide. If you have an opportunity, you can rest assured EMCM will support you whilst you deliver them, through:
Whilst we can assist in process optimisation & validations and upscaling, our core expertise lies in customised routine batch production with competent formulations, processing and filling coupled with a variety of terminal sterilisation techniques as per the requirements or a complete aseptic manufacturing closed system.
Organic solvents, aqueous solutions and suspensions can be produced from small to large scale with a fully automatic closed dosing system to provide a customer specific bulk product. Sterile filtration results in a sterile product for in-line automatic filling.
The production of highly viscous products, like temperature dependent suspensions and gels, is one of the existing expertise and technologies are in place to manufacture these groups of products.
The formulation of all liquids, suspensions & gels (LSG) and can be executed under class A/B aseptic condition before filling in the required primary packaging.
For more detailed information please read our LSG brochure.
EMCM is equipped with a range of (semi-) automatic filling units for the filling of organic solvents, aqueous solutions, gels and suspensions as well as powders. All filling processes can be performed under aseptic conditions and will be validated by media simulations according GMP and ISO requirements:
EMCM has also the possibility to fill powder into vials, pouches and small containers. An example is bone cement powder.
EMCM currently possesses various types of bone cement, cement restrictors as well as an adhesion barrier product for spinal surgeries in its biomaterials portfolio.
EMCM's Tissues business segment is active in the processing of tissue components such as bones, soft tissues, cells and skin of human (eTiss) and of animal origin (eColl), which can further be impregnated with antibiotics (eNova). Our capabilities are in providing safe, clean and effective bone, collagen and innovative products using proprietary supercritical carbon dioxide technology (eCOO | Technology).
For more detailed information, please download our Tissues brochure.
EMCM has grown from a start-up to a mid-sized company that employs over 60 FTE and operates in over 1500 m2 of GMP accredited classified areas (clean rooms), conforming to ISO & GMP standards for compliant manufacturing of medical products.
Using such qualified facilities EMCM produces a broad range of medical products offering complete custom made service and product packages: from product development, through regulatory affairs, purchasing, manufacturing, final packaging, warehousing and distribution in the capacity of a contract manufacturer.
EMCM is always open to explore innovations and work flexibly with its customers. Please feel free to contact us regarding any questions.